NFKB1 and neoplasm: In different malignant diseases, the NF-κB pathway was shown to be strongly activated [32], thereby inducing tumor cell proliferation, apoptosis resistance and ultimately distant disease manifestation directed by epithelial to mesenchymal transition (EMT) [32].